Covered recipient · General Payments record
JUDITH GOLDBERG
General Payments · PY2018–2024
$7,992.70
- Reported across 375 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $478.43 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $308.72 | 4 |
| SANOFI-AVENTIS U.S. LLC | $40.14 | 2 |
| Abbott Laboratories | $24.31 | 1 |
| Corcept Therapeutics | $23.29 | 1 |
| Lilly USA, LLC | $22.32 | 1 |
| IBSA Pharma Inc. | $21.05 | 1 |
| Esperion Therapeutics, Inc. | $19.95 | 1 |
| ABBVIE INC. | $18.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.31 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125371873 | CMS |
| ABBVIE INC. | $18.65 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103810318 | CMS |
| Amgen Inc. | $17.11 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585554 | CMS |
| Amgen Inc. | $134.19 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585558 | CMS |
| Amgen Inc. | $134.19 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585560 | CMS |
| Amgen Inc. | $23.23 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111585556 | CMS |
| Corcept Therapeutics | $23.29 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117734342 | CMS |
| Esperion Therapeutics, Inc. | $19.95 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129436178 | CMS |
| IBSA Pharma Inc. | $21.05 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142977674 | CMS |
| Lilly USA, LLC | $22.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135090483 | CMS |
| SANOFI-AVENTIS U.S. LLC | $24.99 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139598301 | CMS |
| SANOFI-AVENTIS U.S. LLC | $15.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139598311 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.